These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 4302457

  • 1. [On the possible consequences of the diffusion of the virus after poliomyelitis vaccination with attenuated poliovirus vaccine].
    Petrilli FL, Crovari P.
    G Ig Med Prev; 1967; 8(3):313-23. PubMed ID: 4302457
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?].
    Wiersbitzky S.
    Kinderarztl Prax; 1993 May; 61(3):120-1. PubMed ID: 8392122
    [No Abstract] [Full Text] [Related]

  • 4. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I, Rakoto Andrianarivelo M, Akoua-Koffi C, Zeller H, Ehouman A, Morvan JM.
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [Abstract] [Full Text] [Related]

  • 5. [Worldwide eradication of poliomyelitis].
    Rasch G, Schreier E, Kiehl W, Kurth R.
    Wien Klin Wochenschr; 2001 Oct 30; 113(20-21):839-45. PubMed ID: 11732120
    [Abstract] [Full Text] [Related]

  • 6. When can we stop using oral poliovirus vaccine?
    Hull HF, Minor PD.
    J Infect Dis; 2005 Dec 15; 192(12):2033-5. PubMed ID: 16288363
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jul 18; 46(28):641-3. PubMed ID: 9233551
    [Abstract] [Full Text] [Related]

  • 9. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, Sutter RW.
    J Infect Dis; 2003 Dec 15; 188(12):1845-52. PubMed ID: 14673763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polio virus isolates from AFP cases.
    Paul Y, John TJ.
    Indian Pediatr; 1999 Oct 15; 36(10):1061-4. PubMed ID: 10745322
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M, Lottenbach K, Belshe R, Rennels M, Plotkin S, Chumakov K.
    J Infect Dis; 2006 May 15; 193(10):1344-9. PubMed ID: 16619180
    [Abstract] [Full Text] [Related]

  • 14. [Vaccination strategies for the global eradication of poliomyelitis].
    Bompart F.
    Bull Soc Pathol Exot; 2004 Nov 15; 97(4):288-92. PubMed ID: 17304754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F.
    Acta Virol; 2000 Apr 15; 44(2):109-17. PubMed ID: 10989702
    [Abstract] [Full Text] [Related]

  • 19. [Anti-poliomyelitis vaccination].
    Cadrobbi P.
    G Mal Infett Parassit; 1970 Apr 15; 22(4):273-8. PubMed ID: 5515865
    [No Abstract] [Full Text] [Related]

  • 20. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z.
    Przegl Epidemiol; 2005 Apr 15; 59(1):59-68. PubMed ID: 16013411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.